FDA Regulation of AI-Enabled Devices: Congressional Research Overview
A recent Congressional Research Service brief explains how the FDA regulates **AI-enabled health care applications** as medical devices under a risk-based framework spanning Class I to Class III. The report notes that, as of mid-2026, FDA has not yet authorized any generative AI-enabled clinical device but has granted breakthrough designations for certain AI tools while emphasizing safety and effectiveness standards.
About LOG Standards
LOG Standards provides an independent accreditation signal for AI models used in healthcare, helping hospitals, care networks, and AI companies bring clinical AI readiness and governance into clearer conversations.
Our AI Intelligence Briefing tracks the latest developments in AI safety, AI in medicine, mental health AI, clinical AI governance, and regulatory policy — keeping healthcare stakeholders informed about the rapidly evolving AI landscape.